Bellicum Pharmaceuticals, Inc.

BLCM · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$21,837$46,156$35,495$91,028
Short-Term Investments$0$0$0$0
Receivables$0$205$2$303
Inventory$0$0$0$0
Other Curr. Assets$1,964$2,770$3,946$20,523
Total Curr. Assets$23,801$49,131$39,443$111,854
Property Plant & Equip (Net)$22$12$834$3,571
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$307$825
Total NC Assets$22$12$1,141$4,396
Other Assets$0$0$0$0
Total Assets$23,823$49,143$40,584$116,250
Liabilities
Payables$486$90$891$2,643
Short-Term Debt$0$0$825$11,454
Tax Payable$0$0$0$0
Deferred Revenue$0$0$4,165$9,770
Other Curr. Liab.$3,286$6,622$22,985$80,321
Total Curr. Liab.$3,772$6,712$24,701$94,418
LT Debt$0$0$344$26,581
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$18,036$0$18,036$21,468
Total NC Liab.$18,036$18,036$18,380$48,049
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$21,808$24,748$43,081$142,467
Equity
Pref Stock$0$18,036$18,036$21,468
Common Stock$87$85$84$507
Retained Earnings-$575,425-$550,452-$540,747-$533,025
AOCI-$354-$338-$339-$327
Other Equity$577,707$575,100$520,469$485,160
Total Equity$2,015$24,395-$2,497-$26,217
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$23,823$49,143$40,584$116,250
Net Debt-$21,837-$46,156-$34,326-$52,993